$50,000 of LEVI STRAUSS & COMPANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"African Growth and Opportunity Act (P.L. 106-200) reauthorization; Issues related to apparel tariffs. African Growth and Opportunity Act (P.L. 106-200) reauthorization; Issues related to apparel tariffs."
You can find more data on corporate lobbying on Quiver Quantitative.
LEVI Insider Trading Activity
LEVI insiders have traded $LEVI stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $LEVI stock by insiders over the last 6 months:
- DAVID A FRIEDMAN has made 0 purchases and 6 sales selling 58,332 shares for an estimated $1,152,604.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LEVI Hedge Fund Activity
We have seen 111 institutional investors add shares of LEVI stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,907,099 shares (+44.6%) to their portfolio in Q3 2024, for an estimated $63,374,758
- MILLENNIUM MANAGEMENT LLC removed 1,637,734 shares (-85.2%) from their portfolio in Q3 2024, for an estimated $35,702,601
- MARSHALL WACE, LLP removed 1,234,577 shares (-28.9%) from their portfolio in Q3 2024, for an estimated $26,913,778
- AMERIPRISE FINANCIAL INC removed 1,179,704 shares (-45.4%) from their portfolio in Q3 2024, for an estimated $25,717,547
- M. KULYK & ASSOCIATES, LLC added 1,104,224 shares (+2220.8%) to their portfolio in Q3 2024, for an estimated $24,072,083
- QUBE RESEARCH & TECHNOLOGIES LTD added 837,506 shares (+319.0%) to their portfolio in Q3 2024, for an estimated $18,257,630
- ARMISTICE CAPITAL, LLC added 723,000 shares (+208.4%) to their portfolio in Q3 2024, for an estimated $15,761,400
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
